Spire Healthcare Group plc (LON:SPI)
247.50
+1.00 (0.41%)
Oct 1, 2026, 5:15 PM GMT
Spire Healthcare Group Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Spire Healthcare Group stock has a consensus rating of "Buy" and an average price target of 264p. The average 1-year stock price forecast is 6.77% higher than the current stock price, while the lowest is 250p (+1.01%) and the highest is 282p (+13.94%).
Price Target: 264p (+6.77%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Spire Healthcare Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Downgrades 250p | Hold | Downgrades | 250p | +1.01% | Sep 8, 2026 |
| Barclays | Barclays | Buy Maintains 275p | Buy | Maintains | 275p | +11.11% | Sep 8, 2026 |
Unknown Analyst Deutsche Bank No rating | Deutsche Bank | Buy Reiterates 245p | Buy | Reiterates | 245p | -1.01% | May 15, 2026 |
Financial Forecast
Revenue This Year
1.64B
from 1.58B
Increased by 4.13%
Revenue Next Year
1.74B
from 1.64B
Increased by 5.83%
EPS This Year
0.09
from 0.09
Decreased by -5.00%
EPS Next Year
0.17
from 0.09
Increased by 92.28%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.